Lyell Immunopharma, Inc. (LYEL)
22.59
+1.19
(+5.56%)
USD |
NASDAQ |
Feb 23, 16:00
22.59
0.00 (0.00%)
After-Hours: 16:37
Lyell Immunopharma SG&A Expense (Quarterly) : 10.69M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Insmed, Inc. | 212.48M |
| Nektar Therapeutics | 16.07M |
| GT Biopharma, Inc. | 2.748M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Vertex Pharmaceuticals, Inc. | 487.00M |